A detailed history of Jpmorgan Chase & CO transactions in Good Rx Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,296 shares of GDRX stock, worth $31,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,296
Previous 4,210 25.8%
Holding current value
$31,087
Previous $29,000 41.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$6.5 - $8.91 $7,059 - $9,676
1,086 Added 25.8%
5,296 $41,000
Q1 2024

May 10, 2024

SELL
$5.37 - $8.35 $162,641 - $252,896
-30,287 Reduced 87.8%
4,210 $29,000
Q4 2023

Feb 12, 2024

SELL
$4.44 - $6.7 $3,991 - $6,023
-899 Reduced 2.54%
34,497 $231,000
Q3 2023

Nov 14, 2023

SELL
$5.23 - $9.24 $2.63 Million - $4.65 Million
-503,763 Reduced 93.43%
35,396 $199,000
Q2 2023

Aug 11, 2023

BUY
$4.36 - $6.2 $1.16 Million - $1.65 Million
266,908 Added 98.04%
539,159 $2.98 Million
Q1 2023

May 18, 2023

BUY
$4.71 - $6.66 $173,092 - $244,755
36,750 Added 15.61%
272,251 $1.7 Million
Q1 2023

May 11, 2023

BUY
$4.71 - $6.66 $917,178 - $1.3 Million
194,730 Added 477.62%
235,501 $1.47 Million
Q4 2022

Feb 13, 2023

BUY
$4.06 - $5.71 $31,708 - $44,595
7,810 Added 23.69%
40,771 $189,000
Q3 2022

Nov 14, 2022

BUY
$4.67 - $7.81 $28,276 - $47,289
6,055 Added 22.5%
32,961 $154,000
Q2 2022

Aug 11, 2022

BUY
$5.84 - $20.02 $154,322 - $529,028
26,425 Added 5493.76%
26,906 $159,000
Q1 2022

May 11, 2022

SELL
$13.62 - $32.45 $245 - $584
-18 Reduced 3.61%
481 $9,000
Q4 2021

Feb 10, 2022

SELL
$32.11 - $47.16 $506,920 - $744,514
-15,787 Reduced 96.94%
499 $17,000
Q3 2021

Nov 12, 2021

BUY
$29.63 - $46.98 $482,554 - $765,116
16,286 New
16,286 $668,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $495M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.